Evidence map›Paper›PMID 36811648›Full record

ReviewBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz2023

[Establishment of genomic pathogen surveillance to strengthen pandemic preparedness and infection prevention in Germany].

Simone Scheithauer, Alexander Dilthey, Anna Bludau, Sandra Ciesek, Victor Corman, Tjibbe Donker, Tim Eckmanns, Richard Egelkamp, Hajo Grundmann, Georg Häcker and 12 more

Abstract readEnglish AbstractReview
In one paragraph

Review in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Responsive population-based cohorts as platforms for characterising pathogen- and population-level infection dynamics for epidemic prevention, preparedness and response.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Simone ScheithauerInstitut für Krankenhaushygiene und Infektiologie, Universitätsmedizin Göttingen (UMG), Georg-August Universität Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Deutschland. simone.scheithauer@med.uni-goettingen.de.
Alexander DiltheyMedizinische Mikrobiologie und Krankenhaushygiene, Universitätsklinikum Düsseldorf, Düsseldorf, Deutschland.
Anna BludauInstitut für Krankenhaushygiene und Infektiologie, Universitätsmedizin Göttingen (UMG), Georg-August Universität Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Deutschland.
Sandra CiesekInstitut für Medizinische Virologie, Universitätsklinikum Frankfurt, Frankfurt am Main, Deutschland.
Victor CormanInstitut für Virologie, Charité Universitätsmedizin Berlin, Berlin, Deutschland.
Tjibbe DonkerInstitut für Infektionsprävention und Krankenhaushygiene, Universitätsklinikum Freiburg, Freiburg, Deutschland.
Tim EckmannsRobert Koch-Institut, Berlin, Deutschland.
Richard EgelkampNext Generation Sequencing, Niedersächsisches Landesgesundheitsamt, Hannover, Deutschland.
Hajo GrundmannInstitut für Infektionsprävention und Krankenhaushygiene, Universitätsklinikum Freiburg, Freiburg, Deutschland.
Georg HäckerInstitut für Medizinische Mikrobiologie und Hygiene, Universitätsklinikum Freiburg, Freiburg, Deutschland.
Martin KaaseInstitut für Krankenhaushygiene und Infektiologie, Universitätsmedizin Göttingen (UMG), Georg-August Universität Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Deutschland.
Berit LangeAbteilung Epidemiologie, Helmholtz-Zentrum für Infektionsforschung, Braunschweig, Deutschland.
Alexander MellmannInstitut für Hygiene, Universitätsklinikum Münster, Münster, Deutschland.
Martin MielkeRobert Koch-Institut, Berlin, Deutschland.
Mathias PletzInstitut für Infektionsmedizin und Krankenhaushygiene, Universitätsklinikum Jena, Jena, Deutschland.
Bernd SalzbergerInfektiologie, Abteilung für Krankenhaushygiene und Infektiologie, Universitätsklinikum Regensburg, Regensburg, Deutschland.
Andrea ThürmerRobert Koch-Institut, Berlin, Deutschland.
Andreas WidmerAbteilung für Infektiologie und Spitalhygiene, Universitätsspital Basel, Basel, Schweiz.
Lothar H WielerRobert Koch-Institut, Berlin, Deutschland.
Thorsten WolffRobert Koch-Institut, Berlin, Deutschland.
Sören GatermannInstitut für Hygiene und Mikrobiologie, Ruhr-Universität Bochum, Bochum, Deutschland.
Torsten SemmlerRobert Koch-Institut, Berlin, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SARS-CoV‑2 pandemic has shown a deficit of essential epidemiological infrastructure, especially with regard to genomic pathogen surveillance in Germany. In order to prepare for future pandemics, the authors consider it urgently necessary to remedy this existing deficit by establishing an efficient infrastructure for genomic pathogen surveillance. Such a network can build on structures, processes, and interactions that have already been initiated regionally and further optimize them. It will be able to respond to current and future challenges with a high degree of adaptability.The aim of this paper is to address the urgency and to outline proposed measures for establishing an efficient, adaptable, and responsive genomic pathogen surveillance network, taking into account external framework conditions and internal standards. The proposed measures are based on global and country-specific best practices and strategy papers. Specific next steps to achieve an integrated genomic pathogen surveillance include linking epidemiological data with pathogen genomic data; sharing and coordinating existing resources; making surveillance data available to relevant decision-makers, the public health service, and the scientific community; and engaging all stakeholders. The establishment of a genomic pathogen surveillance network is essential for the continuous, stable, active surveillance of the infection situation in Germany, both during pandemic phases and beyond.

Indexed as

COVID-19SARS-CoV-2GenomicsGermanyHumansPandemicsBest practiceFrameworkNetworkStandardisationStrategy

Identifiers

PMID36811648
PMCPMC9945818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.